Trump: "[health] insurance for everybody," Replacing the ACA

Status
Not open for further replies.
Yes, it is a different problem.

I'll reiterate that the payer isn't the solution. If we do nothing other than turn our system into single payer, that won't reduce the cost per capita in any meaningful way. There's a reasonable likelihood that it will increase cost per capita due to increased utilization. In order to address the ridiculous cost per capita that the US has going on... we need to actually address the cost of care, not who is paying the bills.

There are huge administrative costs and inefficiencies associates with the current US system that a single payer universal system would eliminate. These include, but are not limited to: Emphasizing preventative vs costly catastrophic care, removing delay in treatments that make dealing with the illness much more expensive, reduction medical bankruptcy related costs, reduction in administrative burdens and focusing cost cutting on providing more efficient care rather than cutting patients from the insurance rolls.

There is more than enough data at this point to show universal systems are cheaper per capita, and there is at least some data to suggest that single payer universal systems are more efficient and cheaper per capita than regulated insurance based universal systems.
 
There is more than enough data at this point to show universal systems are cheaper per capita, and there is at least some data to suggest that single payer universal systems are more efficient and cheaper per capita than regulated insurance based universal systems.

Is the VA a universal system?

(It is for me, as a disabled veteran, I can get health care anywhere there is VA hospital
or clinic. Emergency health care was paid for by the VA.)
 
There are huge administrative costs and inefficiencies associates with the current US system that a single payer universal system would eliminate. These include, but are not limited to: Emphasizing preventative vs costly catastrophic care, removing delay in treatments that make dealing with the illness much more expensive, reduction medical bankruptcy related costs, reduction in administrative burdens and focusing cost cutting on providing more efficient care rather than cutting patients from the insurance rolls.

There is more than enough data at this point to show universal systems are cheaper per capita, and there is at least some data to suggest that single payer universal systems are more efficient and cheaper per capita than regulated insurance based universal systems.

Most health insurance (there are a few exceptions, generally under short-term care or critical care policies) already emphasize prevention over catastrophic care, and have done so since before ACA.

Although there are some exceptions related to prior authorization and step therapies, most delays in treatment aren't caused by the insurance company. Personal anecdote, of course, but in my case I was able to get in to see a neurologist within a week only because there was a cancellation. The service was covered, there were no openings in schedules. I called five neurologists that were within a reasonable distance of me.

Providing more efficient care is also a provider-side measure. It's not an insurance measure.

Yes, there would be some efficiencies gained by having single payer. And yes, data shows that currently existing universal payer is less expensive than single payer. And I will again reiterate that those universal payers all have cost controls in place.

Who is responsible for paying the bill is independent of how much the bill tallies to. A sustainable system needs both of these things. If you do not address the cost issue in tandem with changing the payer, you will realize only minimal benefits.
 
Yes, it is a different problem.

I'll reiterate that the payer isn't the solution. If we do nothing other than turn our system into single payer, that won't reduce the cost per capita in any meaningful way. There's a reasonable likelihood that it will increase cost per capita due to increased utilization. In order to address the ridiculous cost per capita that the US has going on... we need to actually address the cost of care, not who is paying the bills.

Nothing can be done to cut costs though. To many jobs, some of them highly skilled and paid jobs like yours would end up gone if we went to a more efficient system. That is not politically tolerable.
 
Most health insurance (there are a few exceptions, generally under short-term care or critical care policies) already emphasize prevention over catastrophic care, and have done so since before ACA.

Although there are some exceptions related to prior authorization and step therapies, most delays in treatment aren't caused by the insurance company. Personal anecdote, of course, but in my case I was able to get in to see a neurologist within a week only because there was a cancellation. The service was covered, there were no openings in schedules. I called five neurologists that were within a reasonable distance of me.

Providing more efficient care is also a provider-side measure. It's not an insurance measure.

Yes, there would be some efficiencies gained by having single payer. And yes, data shows that currently existing universal payer is less expensive than single payer. And I will again reiterate that those universal payers all have cost controls in place.

Who is responsible for paying the bill is independent of how much the bill tallies to. A sustainable system needs both of these things. If you do not address the cost issue in tandem with changing the payer, you will realize only minimal benefits.

The bit in bold.

That's not true if there are arbitrary rules forbidding one customer from using their bulk-buying purchasing power to negotiate discounts.
 
Who is responsible for paying the bill is independent of how much the bill tallies to.



This really isn't the case in any business I've ever worked in.

How much the bill tallies to is a negotiation (especially in the world of US healthcare) and if you're going to throw many, many units my way, you'll get a discount. If you're a one-off purchaser. then it's full price please. If you have a lot of friends who are likely to want to buy the same thing, we can talk about it.


Prices are very much dependent on who's paying if the business owner wants repeat business.
 
Nothing can be done to cut costs though. To many jobs, some of them highly skilled and paid jobs like yours would end up gone if we went to a more efficient system. That is not politically tolerable.

I'm ignoring the politics of the situation for the nonce.

I disagree that costs couldn't be cut. Pharmacueticals and Device & Supply manufacturers routinely make 20% to 30% profit margins. Not that those profits are after R&D investments. Salary for a GP ranges from about $100K to $225K. Salary for specialists regularly run in the $300K to $500K ranges.

As for me... a pay cut would suck-diddly-uck Flanders... but it wouldn't be the end of the world. I know full well that my field would take a big hit if the US actually fixed the system. But that doesn't make the system anything other than broken. It is complicated, there are a lot of things that need to be addressed including the effect on unemployment. But at the end of the day, recognizing a problem and declaring an objective is better than pretending it's okay. Then it's down to strategy and tactics - how do we get there with the fewest negative effect?
 
Yes, it is a different problem.

I'll reiterate that the payer isn't the solution. If we do nothing other than turn our system into single payer, that won't reduce the cost per capita in any meaningful way.


How do you know? Taking into account the fact that there is clear, irrefutable, real-life evidence that it has everywhere else it is being done?

There's a reasonable likelihood that it will increase cost per capita due to increased utilization.


Which is why it has driven up the cost per capita every where else it is being done?

Oh. Wait. No, it hasn't.

In order to address the ridiculous cost per capita that the US has going on... we need to actually address the cost of care, not who is paying the bills.


Unless one of the primary drivers of that cost is who is paying the bills.
 
I'm ignoring the politics of the situation for the nonce.

I disagree that costs couldn't be cut. Pharmacueticals and Device & Supply manufacturers routinely make 20% to 30% profit margins. Not that those profits are after R&D investments. Salary for a GP ranges from about $100K to $225K. Salary for specialists regularly run in the $300K to $500K ranges.

This is the approach in Canada, although it's worth mentioning that the Province is not the only purchaser of drugs, just the biggest. And the payers (the citizens/voters/taxpayers) get a demonstrable price break because of the efficiencies introduced by economies of scale, the supplier probably makes about the same profit because of the reduced costs associated with volume (eg: delivery gets really cheap when there's one dropoff site and the customer handles internal distribution).


As for me... a pay cut would suck-diddly-uck Flanders... but it wouldn't be the end of the world. I know full well that my field would take a big hit if the US actually fixed the system.

I wonder if it would actually translate into pay cuts. As opposed to: some roles would completely vanish, others would remain. BC still has actuaries because profit or no profit, planners still need forecasting power vis a vis regional forward planning, capital investments, &c. Also still room for analysts with medical expertise. Cost/benefit economics don't go away with single payer. There is still an emphasis on management by outcome metrics and pursuit of efficiencies.

In contrast, I have never seen a 'commercial' for our universal healthcare program, so anybody currently involved in marketing would be sacked as a result of any such transition. And that's a lot of overhead, my research shows that up to 30% of a for-profit insurance firm in the US' spending is on marketing related activities.

One of the trivial examples of how steering away from a market model reduces costs is brand vs generic preference. I was reading some US HMO marketing publications that explained how important it was to provide customers with branded drugs instead of generic, not because they worked better, but because it improved the survey results for patient satisfaction. All that placebo crap gets tossed out the window in a single payer. The metrics are health, not Yelp stars.


But that doesn't make the system anything other than broken. It is complicated, there are a lot of things that need to be addressed including the effect on unemployment. But at the end of the day, recognizing a problem and declaring an objective is better than pretending it's okay. Then it's down to strategy and tactics - how do we get there with the fewest negative effect?

I think the four centers of resistance are:
  • industry workers whose entire jobs will be eliminated (marketing, administrative, legal)
  • investors whose businesses will see their market evaporate (would the government compensate, for example, Aetna shareowners for the decimation of their customer base?)
  • voters who are convinced that single payer will actually make things worse
  • voters with ideological objection to government intervention regardless of probable benefit even to themselves
 
I'm ignoring the politics of the situation for the nonce.

<snip>


That's convenient.

So you might as well bow out of the conversation entirely, because what passes for (or doesn't, depending on perspective) a health care system in the U.S. is inextricably wrapped up in and dependent on politics.

If you want to exclude that then you might as well limit your arguing to the other sophomores in the dorm room, because that's all the relevance to anything real it will have.
 
<snip>



I think the four centers of resistance are:
  • industry workers whose entire jobs will be eliminated (marketing, administrative, legal)
  • investors whose businesses will see their market evaporate (would the government compensate, for example, Aetna shareowners for the decimation of their customer base?)
  • voters who are convinced that single payer will actually make things worse
  • voters with ideological objection to government intervention regardless of probable benefit even to themselves


I think that those investors deserve exactly as much government compensation as the ones invested in buggy whip manufacturers got.

Investment is not a guarantee of return. It is a risk strategy.

Times change. So do the risks.

Any investor who believes that simply because they have put money into an enterprise it means they deserve government protection on their return for some limitless period of time is in the wrong racket, and needs to switch to a different strategy which is actually supposed to insulate them from their bad decisions.
 
I agree that a monolithic power can set prices. I don't agree that single payer necessarily means lower prices. It needs to explicitly include both elements to get it done - single payer AND price setting. And at the end of the day, it's the price setting that matters most.

Good luck setting prices if you don't represent a large portion of the market. Who is paying matters.
 
I think that those investors deserve exactly as much government compensation as the ones invested in buggy whip manufacturers got.

Investment is not a guarantee of return. It is a risk strategy.

Times change. So do the risks.

Any investor who believes that simply because they have put money into an enterprise it means they deserve government protection on their return for some limitless period of time is in the wrong racket, and needs to switch to a different strategy which is actually supposed to insulate them from their bad decisions.

I'm willing to consider exceptions, depending on what exactly is being proposed. Is this the equivalent of nationalization / expropriation, for example. What are the precedents? For this type of transition there probably aren't any precedents, because other countries were lucky enough to make the call before health insurance grew to be so profitable as a business sector. But they did have to deal with the MDs who argued they were facing losses, and at least a few countries offered compensation. There is, in fact, a case in Canada before the courts right now, addressing this exact concern.
 
How do you know? Taking into account the fact that there is clear, irrefutable, real-life evidence that it has everywhere else it is being done?
Because it's my career field and I've been working in it for 16 years? Sure, it's an appeal to authority, but you asked how I know this. That's how I know it.

Which is why it has driven up the cost per capita every where else it is being done?

Oh. Wait. No, it hasn't.
That is some master's level parsing there.

"If we do nothing other than turn our system into single payer, that won't reduce the cost per capita in any meaningful way. There's a reasonable likelihood that it will increase cost per capita due to increased utilization."
IF we don't also address the cost side, THEN there is a reasonable likelihood that costs would increase. Seriously, don't split things like this when the context is clear.
 
This is the approach in Canada, although it's worth mentioning that the Province is not the only purchaser of drugs, just the biggest. And the payers (the citizens/voters/taxpayers) get a demonstrable price break because of the efficiencies introduced by economies of scale, the supplier probably makes about the same profit because of the reduced costs associated with volume (eg: delivery gets really cheap when there's one dropoff site and the customer handles internal distribution).
Maybe. Depends on the product I would guess. I don't think the delivery costs for drugs would really offset the profit margin. But I also don't have a solid accounting of how much of that profit comes from which countries.

I wonder if it would actually translate into pay cuts. As opposed to: some roles would completely vanish, others would remain. BC still has actuaries because profit or no profit, planners still need forecasting power vis a vis regional forward planning, capital investments, &c. Also still room for analysts with medical expertise. Cost/benefit economics don't go away with single payer. There is still an emphasis on management by outcome metrics and pursuit of efficiencies.

In contrast, I have never seen a 'commercial' for our universal healthcare program, so anybody currently involved in marketing would be sacked as a result of any such transition. And that's a lot of overhead, my research shows that up to 30% of a for-profit insurance firm in the US' spending is on marketing related activities.
Realistically it's probably more a matter of job losses than pay cuts. I was mostly just attempting humor.

One of the trivial examples of how steering away from a market model reduces costs is brand vs generic preference. I was reading some US HMO marketing publications that explained how important it was to provide customers with branded drugs instead of generic, not because they worked better, but because it improved the survey results for patient satisfaction. All that placebo crap gets tossed out the window in a single payer. The metrics are health, not Yelp stars.
Yeah, I get tired of the brand hawking when it comes to drugs. Although there are a few specific cases where there are non-ingredient differences between brand and generic that can come into play. Not often, and they only affect a very small subset of people.

I think the four centers of resistance are:
  • industry workers whose entire jobs will be eliminated (marketing, administrative, legal)
  • investors whose businesses will see their market evaporate (would the government compensate, for example, Aetna shareowners for the decimation of their customer base?)
  • voters who are convinced that single payer will actually make things worse
  • voters with ideological objection to government intervention regardless of probable benefit even to themselves
Yep, I agree with that assessment. Although I'll add another: politicians that are buddy-buddy with lobbyists and think they can leverage the ideological voters to their personal advantage ;)

Most of that last group are probably republicans.
 
That's convenient.

So you might as well bow out of the conversation entirely, because what passes for (or doesn't, depending on perspective) a health care system in the U.S. is inextricably wrapped up in and dependent on politics.

If you want to exclude that then you might as well limit your arguing to the other sophomores in the dorm room, because that's all the relevance to anything real it will have.

The ideological argument of whether we should do a thing doesn't really have a lot of bearing on the discussion of economics and mechanics that need to be considered for it to function.

Seriously, if that's your stance on this, then I suppose none of us should try to objectively discuss social issues like transgender or gay rights, race and ethnicity issues like the justice system, or hell, even reproductive rights. Those are also inextricably wrapped up in and dependent on politics. Guess it's just impossible for anyone to set the politics aside and address the issues objectively, hmm?
 
Good luck setting prices if you don't represent a large portion of the market. Who is paying matters.

You're like the fourth person here who has made a similar comment. I must've really done a bad job at laying this out. Let me try again.

Yes, representing a large part of the market (or all of it in the case of a single payer) allows one to negotiate lower rates.

BUT (and this is my point here) being a single payer all by itself is insufficient UNLESS that price negotiation is an explicit part of the plan.

Being single payer (or at least near-monopoly payer) is a necessary but not sufficient element of bringing the cost of health care down in the US.

Hopefully that's clearer :)
 
I don't think the delivery costs for drugs would really offset the profit margin.

It's just an example of an incremental improvement. The overall benefit depends on the number of shipping destinations and number of shipments per year.

I work in a telco, and we see good savings with economies of scale associated with volume that definitely contribute to margins.

Just as an example, our sales and care team is about 900 staff, supporting X number of transactions per day, massmarket. We ship thousands of phones a day. We handle the same number of transactions per day through each of several single point of contact intermediaries, without the need of all that staff.

An example being that instead of dealing with each lab, the labs have one depot with their own distribution network for all their supplies. We save 99% of our sales agent cost, 90% of our shipping cost, there's one contract instead of a thousand, so legal costs are only a fraction. We pass those savings on to the B2B customer and they pay us about a third what a retail customer would (note: they absorb some of that cost by taking some tacit support activities in house). Bonus: we actually have a higher margin after all this consolidation of activity.

As a customer moves up the supply chain into larger volumes, even on a commodity with minimal servicing expenses like packages of pills, the unit price can easily halve, mostly due to reduced logistics overhead. (logistics meaning distribution)

Patients are getting more than just bare bones pills, though... their treatments are complicated, and having a single supplier irons out a lot of non-distribution logistics as well. A single records management interface, for example. I did software project management for an insurance company, and the fact that they had to build interfaces for all their different customer one-off records tools was something I found borderline intolerable. Basically 90% of the budget was testing field mapping of the different schema. What a *********** waste of resources getting sucked out of what could be going to actual patient care. This is one economic segment where competition is just flat out inefficient.
 
Last edited:
Yep, I agree with that assessment. Although I'll add another: politicians that are buddy-buddy with lobbyists and think they can leverage the ideological voters to their personal advantage

I was mentally compartmentalizing lobbyists with the 2nd bullet regarding shareowners who are concerned about lost future earnings.

All four categories probably have lobbying representation, as do patient advocates who are pitching single payer.
 
I'm ignoring the politics of the situation for the nonce.

I disagree that costs couldn't be cut. Pharmacueticals and Device & Supply manufacturers routinely make 20% to 30% profit margins. Not that those profits are after R&D investments. Salary for a GP ranges from about $100K to $225K. Salary for specialists regularly run in the $300K to $500K ranges.

As for me... a pay cut would suck-diddly-uck Flanders... but it wouldn't be the end of the world. I know full well that my field would take a big hit if the US actually fixed the system. But that doesn't make the system anything other than broken. It is complicated, there are a lot of things that need to be addressed including the effect on unemployment. But at the end of the day, recognizing a problem and declaring an objective is better than pretending it's okay. Then it's down to strategy and tactics - how do we get there with the fewest negative effect?

Banks were to big to fail, healthcare is too big to fix. All we can to is try to prevent it from getting even worse like what they did with epipen.
 
Status
Not open for further replies.

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom